n
|
16
|
12
|
28
| |
Age (in years)
|
77.8 ±6.9
|
75.3 ±5.8
|
76.8 ±6.5
|
0.2856
|
Gender (proportion of females)
|
37.5%
|
33.3%
|
35.7%
|
1.0000
|
Gender (proportion of males)
|
62.5%
|
66.7%
|
64.3%
| |
MMSE
|
28.0 ±1.7
|
26.3 ±1.6
|
27.3 ±1.8
|
0.0133
|
CDR
|
0.4 ±0.2
|
0.5 ±0.0
|
0.5 ±0.1
|
0.2317
|
ApoE ε4 (proportion of subjects with 0 alleles)
|
56.3%
|
16.7%
|
39.3%
|
0.0550
|
ApoE ε4 (proportion of subjects with 1 allele)
|
37.5%
|
50.0%
|
42.9%
| |
ApoE ε4 (proportion of subjects with 2 alleles)
|
6.3%
|
33.3%
|
17.9%
| |
Time to final diagnosis in months
|
41.3 ±22.4
|
28.4 ±14.2
|
35.7 ±20.1
|
<0.2457
|